Keyphrases
Multiple Myeloma
100%
Gain Loss
100%
Bone Loss
100%
Erythropoietin Therapy
100%
Bone Marrow
25%
Anemia
25%
Immune Response
12%
Immune System
12%
Transcript Level
12%
Double-edged Sword
12%
Direct Action
12%
Study Support
12%
Mouse Model
12%
Disease Progression
12%
Macrophages
12%
Bone Resorption
12%
Nuclear factor-κB
12%
Multiple Myeloma Patients
12%
Interleukin-6
12%
CD138
12%
Phagocytosis
12%
CT Analysis
12%
Erythropoietin
12%
Bone Damage
12%
Recombinant Human EPO
12%
Distal Femur
12%
Bone Marrow-derived Macrophages
12%
Plasma Cell Malignancy
12%
Healthy Mice
12%
Monoclonal Immunoglobulin
12%
Osteolytic Lesions
12%
IgG2b
12%
High-resolution micro-CT
12%
Bone Marrow Macrophages
12%
Multiple Myeloma Progression
12%
CD11b+
12%
Medicine and Dentistry
Multiple Myeloma
100%
Osteolysis
100%
Erythropoietin
100%
Anemia
20%
Macrophage
20%
Disease
10%
Immune System
10%
In Vitro
10%
Cancer
10%
Immune Response
10%
Interleukin-6
10%
Bone Atrophy
10%
Disease Exacerbation
10%
Osteoclast Differentiation Factor
10%
Bone Marrow Derived Macrophage
10%
Immunoglobulin Enhancer Binding Protein
10%
Plasma Cell
10%
Paraprotein
10%
Phagocytosis
10%
Immunoglobulin G2b
10%
Bone Injury
10%
Distal Femur
10%
Immunology and Microbiology
Multiple Myeloma
100%
Osteolysis
100%
Erythropoietin
100%
Mouse
50%
Macrophage
20%
Mouse Model
10%
Immune Response
10%
Immune System
10%
Phagocytosis
10%
Plasma Cell
10%
Interleukin-6
10%
RANKL
10%
Immunoglobulin Enhancer Binding Protein
10%
Distal Femur
10%
Immunoglobulin G2b
10%
Myeloma Protein
10%
Bone Marrow-Derived Macrophage
10%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Erythropoietin
100%
Mouse
50%
Anemia
20%
Disease
10%
Mouse Model
10%
Bone Atrophy
10%
Disease Exacerbation
10%
Paraprotein
10%
Immunoglobulin Enhancer Binding Protein
10%
Bone Injury
10%
Immunoglobulin G2b
10%
Osteoclast Differentiation Factor
10%